Clinical safety and feasibility of a novel implantable neuroimmune modulation device for the treatment of rheumatoid arthritis: initial results from the randomized, double-blind, sham-controlled RESET-RA study.
- DOI
- 10.1186/s42234-023-00138-x
- Published
- 2024 Mar 13
- Container
- Bioelectronic medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s42234-023-00138-x,
title = {Clinical safety and feasibility of a novel implantable neuroimmune modulation device for the treatment of rheumatoid arthritis: initial results from the randomized, double-blind, sham-controlled RESET-RA study.},
author = {Peterson D and Van Poppel M and Boling W and Santos P and Schwalb J and Eisenberg H and Mehta A and Spader H and Botros J and Vrionis FD and Ko A and Adelson PD and Lega B and Konrad P and Calle G and Vale FL and Bucholz R and Richardson RM},
year = {2024},
journal = {Bioelectronic medicine},
doi = {10.1186/s42234-023-00138-x},
url = {https://doi.org/10.1186/s42234-023-00138-x}
}RIS
TY - JOUR TI - Clinical safety and feasibility of a novel implantable neuroimmune modulation device for the treatment of rheumatoid arthritis: initial results from the randomized, double-blind, sham-controlled RESET-RA study. AU - Peterson D AU - Van Poppel M AU - Boling W AU - Santos P AU - Schwalb J AU - Eisenberg H AU - Mehta A AU - Spader H AU - Botros J AU - Vrionis FD AU - Ko A AU - Adelson PD AU - Lega B AU - Konrad P AU - Calle G AU - Vale FL AU - Bucholz R AU - Richardson RM PY - 2024 JO - Bioelectronic medicine DO - 10.1186/s42234-023-00138-x UR - https://doi.org/10.1186/s42234-023-00138-x ER -
APA
D, P., M, V. P., W, B., P, S., J, S., H, E., A, M., H, S., J, B., FD, V., A, K., PD, A., B, L., P, K., G, C., FL, V., R, B., & RM, R. (2024). Clinical safety and feasibility of a novel implantable neuroimmune modulation device for the treatment of rheumatoid arthritis: initial results from the randomized, double-blind, sham-controlled RESET-RA study.. Bioelectronic medicine. https://doi.org/10.1186/s42234-023-00138-x
Source records
- pubmed · retrieved 2026-09-26T01:36:52.399Z